EFFICACY AND SAFETY OF STANDARDISED FERRIC CARBOXYMALTOSE DOSES VS INDIVIDUALLY CALCULATED IRON SUCROSE DOSES FOR IBD-ASSOCIATED IRON DEFICIENCY ANAEMIA: A MULTICENTRE, RANDOMISED CONTROLLED TRIAL

(1) Medical University, Vienna, Austria

(2) Hôpital Lariboisiere, Paris, France

(3) University Hospital, Birmingham, United Kingdom

(4) State Scientific Center ofColoproctology, Moscow, RussianFederation

(5) Zentrum für Viszeral- undErnährungsmedizin, Frankfurt a.M., Germany

(6) GastroenterologischeGemeinschaftspraxis, Minden, Germany

(7) National University, Uzhgorod, Ukraine

(8) Vifor Pharma, Glattbrugg, Switzerland



This item was part of the Inflammatory Bowel Disease I session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A193